GLUCOTROL

This brand name is authorized in United States. It is also authorized in Estonia, Hong Kong SAR China, Lithuania, Romania, Turkey.

Active ingredients

The drug GLUCOTROL contains one active pharmaceutical ingredient (API):

1	Glipizide UNII X7WDT95N5C - GLIPIZIDE
	Glipizide is an oral blood-glucose-lowering drug of the sulfonylurea class. The primary mode of action of glipizide is the stimulation of insulin secretion from the beta-cells of pancreatic islet tissue.
	Read more about Glipizide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
GLUCOTROL Tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)
GLUCOTROL XL Extended-release tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BB07	Glipizide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1484412
HK	Department of Health Drug Office	41847
LT	Valstybinė vaistų kontrolės tarnyba	1003801, 1003802
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65038001, W65039001
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308031013, 8699532031006
US	FDA, National Drug Code	0049-0170, 0049-0174, 0049-0178, 0049-4110, 0049-4120